Immatics surges following Adoptive Cell Therapy study clinical data update Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Immatics (IMTX) up 28% after providing a clinical data update from the dose escalation cohorts of the company's ongoing Phase 1 trials for its engineered Adoptive Cell Therapy approach
- Tonix Pharmaceuticals (TNXP) up 12% after announcing preliminary results following vaccination of non-human primates with TNX-1800, a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 spike protein
- Coherent (COHR) up 3% after Lumentum (LITE) confirmed that it delivered to the company's board a revised proposal to acquire Coherent in a cash and stock transaction valued at $6.9B
UP AFTER EARNINGS -
- Crowdstrike (CRWD) up 2%
- Mistras (MG) up 3%
DOWN AFTER EARNINGS -
- Pinduoduo (PDD) down 7%
-
Cintas (CTAS) down 1%
- Kingsoft Cloud (KC) down 8%
- Surgalign (SRGA) down 12%
LOWER -
- Plug Power (PLUG) down 15% after announcing that it will restate its previously issued financial statements for fiscal years 2018 and 2019 and its quarterly filings for 2019 and 2020
Symbols:
IMTX TNXP COHR CRWD MG PDD CTAS KC SRGA PLUG Keywords: Fly Intel, Wall Street, Top Stories, Stocks